{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T05:10:37Z","timestamp":1772514637417,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Chest pain occurs in approximately one-quarter of patients with FMF, the most common monogenic autoinflammatory disease characterized by recurrent attacks of fever and serositis. This study evaluated a large, genetically homogeneous pediatric FMF cohort carrying biallelic pathogenic exon 10 MEFV variants to describe their demographic, clinical, and genetic characteristics, and to compare patients with and without chest pain to better define this manifestation within the FMF spectrum. This cross-sectional single-center study included 918 pediatric FMF patients with biallelic pathogenic\n                    <jats:italic>MEFV<\/jats:italic>\n                    exon 10 variants followed between June 2016 and February 2025. Demographic, clinical, and genetic data were collected retrospectively, and comparative analyses were performed between patients with and without chest pain. The cohort included 456 females (49.7%), with a median age of onset of 4.0\u00a0years and diagnosis age of 6.0\u00a0years. The most common genotype was M694V\/M694V (48.9%), and 12.4% had colchicine resistance. Chest pain occurred in 218 (23.7%) patients, all pleuritic in origin, with no pericarditis. Those with chest pain had higher annual attack frequency, more abdominal pain (95% vs. 87%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001) and greater colchicine resistance (21.1% vs. 9.7%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.001). The M694V\/M694V genotype was significantly more frequent in those with chest pain (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.017). Among patients presenting with chest pain, radiologically confirmed pleural effusion was detected in 5% during at least one of their evaluated attacks, predominantly among those with colchicine resistance.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : In this large genetically homogeneous pediatric FMF cohort, chest pain was a frequent pleuritic manifestation. Patients with chest pain showed higher attack frequency and greater colchicine resistance, particularly among M694V homozygotes. Although rare, detected pleural effusion in patients with chest pain was associated with a significantly higher rate of colchicine resistance.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Chest pain is a recognized but variably reported manifestation of FMF, usually pleuritic in origin.<\/jats:italic>\n                              \u2022\n                              <jats:italic>The M694V homozygous genotype is associated with more severe inflammatory phenotypes.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>In a large genetically homogeneous pediatric cohort, chest pain occurred in nearly one-quarter of patients and was linked to higher attack frequency.<\/jats:italic>\n                              \u2022\n                              <jats:italic>Chest pain was strongly associated with colchicine resistance and more frequent in M694V\/M694V patients. Additionally, a high frequency of colchicine resistance was observed in patients with detected pleural effusion.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-06785-x","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:10:58Z","timestamp":1770786658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of pediatric FMF patients with biallelic pathogenic exon 10 variants: focus on chest pain"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4801-6605","authenticated-orcid":false,"given":"Eray","family":"Tunce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4283-0921","authenticated-orcid":false,"given":"S\u0131la","family":"Atamy\u0131ld\u0131z U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9487-4464","authenticated-orcid":false,"given":"Ekin \u0130layda","family":"\u00c7a\u011flar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8691-940X","authenticated-orcid":false,"given":"Neslihan","family":"Kara \u00c7anl\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5079-5644","authenticated-orcid":false,"given":"Bet\u00fcl","family":"S\u00f6zeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"6785_CR1","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","volume":"351","author":"E Ben-Chetrit","year":"1998","unstructured":"Ben-Chetrit E, Levy M (1998) Familial mediterranean fever. Lancet 351:659\u2013664. https:\/\/doi.org\/10.1016\/S0140-6736(97)09408-7","journal-title":"Lancet"},{"issue":"2","key":"6785_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/rheumatology\/kead439","volume":"63","author":"E Ben-Chetrit","year":"2024","unstructured":"Ben-Chetrit E (2024) Old paradigms and new concepts in familial Mediterranean fever (FMF): an update 2023. Rheumatology 63(2):309\u2013318. https:\/\/doi.org\/10.1093\/rheumatology\/kead439","journal-title":"Rheumatology"},{"key":"6785_CR3","doi-asserted-by":"publisher","unstructured":"Egeli BH, U\u011furlu S (2020) Familial mediterranean fever: clinical state of the art. QJM hcaa291. https:\/\/doi.org\/10.1093\/qjmed\/hcaa291","DOI":"10.1093\/qjmed\/hcaa291"},{"issue":"2","key":"6785_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/rheumatology\/kead465","volume":"63","author":"M Bektas","year":"2024","unstructured":"Bektas M, Koca N, Oguz E et al (2024) Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey. Rheumatology (Oxford) 63(2):319\u2013328. https:\/\/doi.org\/10.1093\/rheumatology\/kead465","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"6785_CR5","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1093\/rheumatology\/keaf181","volume":"64","author":"A Vitale","year":"2025","unstructured":"Vitale A, Caggiano V, Sbalchiero J et al (2025) Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry. Rheumatology (Oxford) 64(8):4776\u20134787. https:\/\/doi.org\/10.1093\/rheumatology\/keaf181","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"6785_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrrheum.2013.174","volume":"10","author":"S Ozen","year":"2014","unstructured":"Ozen S, Bilginer Y (2014) A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol 10(3):135\u2013147. https:\/\/doi.org\/10.1038\/nrrheum.2013.174","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"6785_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/RHU.0000000000002165","volume":"31","author":"E Tunce","year":"2025","unstructured":"Tunce E, U\u00e7ar SA, Co\u015fkuner T et al (2025) Preliminary evaluation for the development of a scoring system to predict homozygous M694V genotype in familial mediterranean fever patients: a single-center study. J Clin Rheumatol 31(1):7\u201311. https:\/\/doi.org\/10.1097\/RHU.0000000000002165","journal-title":"J Clin Rheumatol"},{"key":"6785_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00063198-199909000-00011","volume":"5","author":"A Livneh","year":"1999","unstructured":"Livneh A, Langevitz P, Pras M (1999) Pulmonary associations in familial Mediterranean fever. Curr Opin Pulm Med 5:326\u2013331. https:\/\/doi.org\/10.1097\/00063198-199909000-00011","journal-title":"Curr Opin Pulm Med"},{"issue":"12","key":"6785_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122111","volume":"17","author":"G Tarantino","year":"2016","unstructured":"Tarantino G, Esposito S, Andreozzi L, Bracci B, D\u2019Errico F, Rigante D (2016) Lung involvement in children with hereditary autoinflammatory disorders. Int J Mol Sci 17(12):2111. https:\/\/doi.org\/10.3390\/ijms17122111","journal-title":"Int J Mol Sci"},{"issue":"2","key":"6785_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/s0272-5231(01)00002-8","volume":"23","author":"M Lidar","year":"2002","unstructured":"Lidar M, Pras M, Langevitz P, Livneh A (2002) Thoracic and lung involvement in familial Mediterranean fever (FMF). Clin Chest Med 23(2):505\u2013511. https:\/\/doi.org\/10.1016\/s0272-5231(01)00002-8","journal-title":"Clin Chest Med"},{"issue":"6","key":"6785_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.24953\/turkjped.2023.227","volume":"65","author":"EN Sunar-Yayla","year":"2023","unstructured":"Sunar-Yayla EN, \u015eenol PE, Y\u0131ld\u0131r\u0131m DG, S\u00f6ylemezo\u011flu O (2023) Chest pain in children with familial Mediterranean fever. Turk J Pediatr 65(6):973\u2013979. https:\/\/doi.org\/10.24953\/turkjped.2023.227","journal-title":"Turk J Pediatr"},{"issue":"8","key":"6785_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","volume":"78","author":"M Gattorno","year":"2019","unstructured":"Gattorno M, Hofer M, Federici S et al (2019) Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis 78(8):1025\u20131032. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215048","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6785_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.ard.2025.01.028","volume":"84","author":"S Ozen","year":"2025","unstructured":"Ozen S, Sa\u011f E, Oton T et al (2025) EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update. Ann Rheum Dis 84(6):899\u2013909. https:\/\/doi.org\/10.1016\/j.ard.2025.01.028","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"6785_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s00431-025-06478-x","volume":"184","author":"C Ozbakir","year":"2025","unstructured":"Ozbakir C, Altug GO (2025) The impact of homozygous mutations in exon 10 on musculoskeletal findings in children with familial mediterranean fever. Eur J Pediatr 184(10):620. https:\/\/doi.org\/10.1007\/s00431-025-06478-x","journal-title":"Eur J Pediatr"},{"key":"6785_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.805919","volume":"9","author":"K \u00d6zt\u00fcrk","year":"2022","unstructured":"\u00d6zt\u00fcrk K, Co\u015fkuner T, Baglan E et al (2022) Real-life data from the largest pediatric Familial Mediterranean Fever cohort. Front Pediatr 9:805919. https:\/\/doi.org\/10.3389\/fped.2021.805919","journal-title":"Front Pediatr"},{"issue":"8","key":"6785_CR16","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1093\/rheumatology\/keaf221","volume":"64","author":"E Tunce","year":"2025","unstructured":"Tunce E, Atamy\u0131ld\u0131zU\u00e7ar S, Polat MC et al (2025) Predicting homozygous M694V genotype in paediatric FMF: multicentre analysis and scoring system proposal. Rheumatology (Oxford) 64(8):4816\u20134824. https:\/\/doi.org\/10.1093\/rheumatology\/keaf221","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"6785_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2025.105888","volume":"92","author":"E Tunce","year":"2025","unstructured":"Tunce E, Atamyildiz U\u00e7ar S, S\u00f6zeri B (2025) Different arthritis patterns in pediatric familial Mediterranean fever: focus on exon 10 biallelic pathogenic genotypes. Joint Bone Spine 92(5):105888. https:\/\/doi.org\/10.1016\/j.jbspin.2025.105888","journal-title":"Joint Bone Spine"},{"issue":"3","key":"6785_CR18","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/rheumatology\/kead242","volume":"63","author":"ED Batu","year":"2024","unstructured":"Batu ED, \u015eener S, Arslanoglu Aydin E et al (2024) A score for predicting colchicine resistance at the time of diagnosis in familial Mediterranean fever: data from the TURPAID registry. Rheumatology (Oxford) 63(3):791\u2013797. https:\/\/doi.org\/10.1093\/rheumatology\/kead242","journal-title":"Rheumatology (Oxford)"},{"key":"6785_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.gene.2017.05.013","volume":"626","author":"N Cekin","year":"2017","unstructured":"Cekin N, Akyurek ME, Pinarbasi E, Ozen F (2017) MEFV mutations and their relation to major clinical symptoms of familial Mediterranean fever. Gene 626:9\u201313. https:\/\/doi.org\/10.1016\/j.gene.2017.05.013","journal-title":"Gene"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06785-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-06785-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-06785-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T03:31:01Z","timestamp":1772508661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-06785-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6785"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-06785-x","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"22 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}